-
Georgia refrigeration company sues EPA after five-year HFC reprieve
-
HoloCoder technology promises brighter smartphone images and 3D depth data
-
EU proposes broad consumer safeguards for apps, subscriptions and ticketing
-
Early Black Friday Walking Pad Deals: Urevo and WalkingPad Discounts
-
Nvidia faces scrutiny over alleged Chinese intelligence link to Jensen Huang
-
Radical Numerics develops offline AI tool to detect engineered pathogens
-
Chennai orders inquiry after dogs die at shelter; two veterinarians face action
-
Kiara Advani Reveals Sidharth Malhotra’s Reaction to Toxic Backlash
-
Startup turns Chennai’s history and culture into an interactive world
-
Four firms compete to design Chennai’s model mobility corridors
-
Chennai venue launches month-long festival devoted to full-length theatre
-
Study Finds Climate Change Threatens Cacti More Than Previously Thought
-
New Bay of Bengal low may form November 13 as Tamil Nadu outlook remains unclear
-
एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी
-
ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar
-
АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания
-
알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제
-
أليكس بودي وSCANDIC PAY: بطاقات Mastercard وVISA — جيل جديد من المدفوعات
-
ALEX BODIとSCANDIC PAY:Mastercard・VISAカードによる新世代の決済
-
ALEX BODI 與 SCANDIC PAY:Mastercard 與 VISA 卡——新一代支付方式
-
ALEX BODI a SCANDIC PAY: karty Mastercard a VISA – nová generace plateb
-
ΑΛΕΞ ΜΠΟΝΤΙ και SCANDIC PAY: κάρτες Mastercard και VISA — μια νέα γενιά πληρωμών
-
ALEX BODI i SCANDIC PAY: karty Mastercard i VISA — nowa generacja płatności
-
АЛЕКС БОДІ та SCANDIC PAY: картки Mastercard і VISA — нове покоління платежів
-
АЛЕКС БОДИ и SCANDIC PAY: карты Mastercard и VISA — новое поколение платежей
-
ALEX BODI and SCANDIC PAY: Mastercard and VISA Cards – A New Generation of Payments
-
ALEX BODI și SCANDIC PAY: Cardurile Mastercard și VISA – o nouă generație de plăți
-
Maswanganyi Clarifies Pirates Allegiance Amidst Career Transition
-
Search Underway for 'Dooars Rani' Tigress After Second Escape from Buxa Tiger Reserve
-
Teatro Mayor Unveils 152-Performance 2027 Season Highlighting Beethoven and García Márquez
Chemical giant Bayer to cut management jobs after huge loss
German chemicals giant Bayer said Wednesday it would cut management jobs and was examining splitting off one of its divisions after reporting a massive third-quarter loss.
The maker of Aspirin has long been under pressure from activist investors as its problems mounted, and earlier this year brought in a new CEO to help steer the company in a new direction.
It reported a net loss nearly 4.6 billion euros ($4.9 billion) from July to September, compared to a profit of nearly 550 million euros in the same period last year, dragged down by massive writedowns at its agrochemicals division.
This was linked to losses related to higher interest rates, and also reflects ongoing problems in the division due to falling sales and prices of its key glyphosate-based herbicides.
"We're not happy with this year's performance," new chief executive Bill Anderson said in a statement.
The company said it plans "remove multiple layers of management and coordination" by the end of the year, which will include "a significant reduction in the workforce".
Bayer did not say how many jobs might be affected.
"95 percent of the decision-making in the organisation will shift from managers to the people doing the work," said Anderson.
The diversified group -- whose products include medicines, seeds and crop chemicals -- said it was looking at splitting off either its consumer health or crop science division.
Splitting the company into three businesses had been examined, but ruled out, it said.
Further details will be disclosed in March, it said. Splitting the company into at least two parts -- the agricultural and pharmaceutical businesses -- to contain problems has been a key demand of investors.
Bayer has faced problems since its 2018 takeover of US firm Monsanto.
The German conglomerate inherited Monsanto's legal woes around its Roundup glyphosate-based weedkiller, and has since faced a wave of lawsuits in the United States over claims it causes cancer.
Bayer denies this.
O.Karlsson--AMWN